1.
Chest
; 86(4): 644-5, 1984 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-6478911
RESUMO
Fatal pulmonary hemorrhage occurred on the eighth day of moxalactam therapy. No other pharmacologic agent or obvious cause could be attributed to the hemoptysis. Moxalactam-induced pulmonary hemorrhage should be included in the differential diagnosis of an infiltrate when moxalactam is being administered.